Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice
- 28 February 1995
- journal article
- research article
- Published by Elsevier BV in Tubercle and Lung Disease
- Vol. 76 (1), 51-58
- https://doi.org/10.1016/0962-8479(95)90580-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbitsAntimicrobial Agents and Chemotherapy, 1993
- Activity of clarithromycin against Mycobacterium avium complex infection in beige miceAntimicrobial Agents and Chemotherapy, 1992
- Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in miceAntimicrobial Agents and Chemotherapy, 1992
- Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDSThe Lancet, 1991
- In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycinsAntimicrobial Agents and Chemotherapy, 1991
- In vitro and in vivo activities of clarithromycin against Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 1989
- Mycobacteria Other than Mycobacterium tuberculosis: Review of Microbiologic and Clinical AspectsClinical Infectious Diseases, 1987
- Mycobacterial Infections in. AIDS Patients, with an Emphasis on the Mycobacterium avium ComplexClinical Infectious Diseases, 1986
- The beige mutation in the mouse selectively impairs natural killer cell functionNature, 1979
- Proposed Numbering Scheme for Mycobacterial Serotypes by AgglutinationInternational Journal of Systematic and Evolutionary Microbiology, 1973